Doug Mager
Impact in
- Psychiatry and Mental health top 5%
- Attention Deficit Hyperactivity Disorder
- Schizophrenia research and treatment
- Epidemiology top 10%
- Substance Abuse Treatment and Outcomes
Papers in
-
- Substance Abuse Treatment and Outcomes 5
-
- Schizophrenia research and treatment 4
- Co-authors
- Bridget F. Grant (3 shared papers)Deborah S. Hasin (2 shared papers)Somnath Chatterji (2 shared papers)R Vraşti (2 shared papers)Wilson M. Compton (4 shared papers)Linda B. Cottler (3 shared papers)Emily R. Cox (3 shared papers)Brenda R. Motheral (3 shared papers)
- Journals
- Drug and Alcohol Dependence (4 papers)American Journal on Addictions (2 papers)PEDIATRICS (1 paper)European Addiction Research (1 paper)PubMed (2 papers)
- Partner nations
- United StatesIndiaSwitzerland
In The Last Decade
Doug Mager
10 papers receiving 862 citations
Peers
Comparison fields: 5 of 63
- Psychiatry and Mental health 160
- Epidemiology 325
- Clinical Psychology 198
- Pharmacology 90
- Toxicology 13
Countries citing papers authored by Doug Mager
This map shows the geographic impact of Doug Mager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doug Mager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doug Mager more than expected).
Fields of papers citing papers by Doug Mager
This network shows the impact of papers produced by Doug Mager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doug Mager. The network helps show where Doug Mager may publish in the future.
Co-authors
The 23 scholars most cited alongside Doug Mager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 260 | |
| 2 | 1997 | 234 | |
| 3 | 2003 | 151 | |
| 4 | 1998 | 102 | |
| 5 | 1995 | 42 | |
| 6 | 1997 | 36 | |
| 7 | 1994 | 28 | |
| 8 | 1994 | 17 | |
| 9 | Prescribing COX-2s for patients new to cyclo-oxygenase inhibition therapy. | 2003 | 13 |
| 10 | Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s). | 2003 | 7 |
About Doug Mager
Doug Mager is a scholar working on Epidemiology, Psychiatry and Mental health, Cognitive Neuroscience, Cellular and Molecular Neuroscience and Pharmacology, having authored 10 papers that have together received 890 indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (5 papers), Schizophrenia research and treatment (4 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Sleep and Wakefulness Research (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Health Policy Implementation Science (1 paper), Neuroethics, Human Enhancement, Biomedical Innovations (1 paper) and Alcohol Consumption and Health Effects (1 paper). The work is most often cited by research in Psychiatry and Mental health (160 citations), Epidemiology (325 citations), Clinical Psychology (198 citations), Pharmacology (90 citations) and Toxicology (13 citations). Doug Mager has collaborated with scholars based in United States, India and Switzerland. Frequent co-authors include Bridget F. Grant, Deborah S. Hasin, Somnath Chatterji, R Vraşti, Wilson M. Compton, Linda B. Cottler, Emily R. Cox, Brenda R. Motheral, John B. Saunders and Rochelle Henderson. Their work appears in journals such as Drug and Alcohol Dependence, American Journal on Addictions, PEDIATRICS, European Addiction Research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.